EGFR Mutation Analysis
The EGFR Mutation Analysis, also known as the Epidermal Growth Factor Receptor Mutation Analysis, helps guide treatment and determines if an individual with lung cancer will respond to targeted therapy and subsequently, what type of therapy will likely be of most benefit. The analysis singles out specific activating mutations in the EGFR gene found in DNA cells in tumour tissue which can lead to uncontrolled growth of cancer cells.
Accreditation
Benefits
- Early detection
- Used to detect tumours present in bodily fluids (such as blood) in minute quantities
Recommended For
- Patients harbouring sensitising EGFR mutations
- East Asian patients with lung adenocarcinoma
Process
A sample of the tumour via a biopsy will be sent for testing.
Results will be released within 5 to 7 business days upon receipt of specimen.
Downloads
- Early detection
- Used to detect tumours present in bodily fluids (such as blood) in minute quantities
- Patients harbouring sensitising EGFR mutations
- East Asian patients with lung adenocarcinoma
A sample of the tumour via a biopsy will be sent for testing.
Results will be released within 5 to 7 business days upon receipt of specimen.
